title: Vasoactive intestinal peptide enhances immunoglobulin production and growth in human plasma cells via mechanisms that may involve protein kinase C.
abstract: The effects of various neuropeptides on human plasma cells were studied. Of the various neuropeptides tested, vasoactive intestinal peptide (VIP) enhanced Ig production and growth in human plasma cell lines, IM-9 and AF-10, and in plasma cells generated in vivo (four out of four patients with plasma cell leukemia) and in vitro. In contrast, other neuropeptides (neuropeptide Y, somatostatin, substance P, peptide YY, neurokinin A, calcitonin gene-related peptide, chole-cystokinin octapeptide, and beta-endorphin) were ineffective. Moreover, VIP-induced enhancement was specifically blocked by VIP receptor antagonist. Among the various cytokines, IL-6, GH, and insulin-like growth factor I (IGF-I) also enhanced Ig production and thymidine uptake in plasma cells. However, VIP-induced enhancement was not mediated by IL-6, GH, or IGF-I because antibodies to these cytokines failed to block VIP-induced enhancement. Phorbol 12,13 dibutyrate enhanced Ig production and thymidine uptake in plasma cells, and the Phorbol 12,13 dibutyrate-induced enhancement was blocked by H7 (a protein kinase C inhibitor) but not by H8 (a protein kinase A inhibitor). Similarly, VIP-induced enhancement was blocked by H7 but not by H8. Collectively, VIP enhances plasma cell responses via mechanisms that may involve protein kinase C.
authors.affiliation: Department of Pediatrics, Unitika Central Hospital, Uji, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Kimata
authors.forename: A
authors.initials: A
authors.lastname: Yoshida
authors.forename: C
authors.initials: C
authors.lastname: Ishioka
authors.forename: M
authors.initials: M
authors.lastname: Fujimoto
authors.forename: K
authors.initials: K
authors.lastname: Furusho
mesh_terms: D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D006801:Humans; D007136:Immunoglobulins / Q000096:biosynthesis*; D007700:Kinetics; D009479:Neuropeptides / Q000494:pharmacology; D010950:Plasma Cells / Q000166:cytology* / Q000378:metabolism*; D011493:Protein Kinase C / Q000502:physiology*; D018013:Receptors, Neuropeptide / Q000378:metabolism; D012680:Sensitivity and Specificity; D014660:Vasoactive Intestinal Peptide / Q000494:pharmacology*
chemical_list: D007136:Immunoglobulins; D009479:Neuropeptides; D018013:Receptors, Neuropeptide; D014660:Vasoactive Intestinal Peptide; D011493:Protein Kinase C